Open Source In The Pharmaceutical Industry
[Jose's comment]
You may find this older (2003) paper of interest.
New innovation and development models may be needed as the pharma industry faces a “patent cliff” {http://www.economist.com/theworldin/PrinterFriendly.cfm?story_id=14742621}.
The role of Open Source-like development and business models are not limited to software development any more. Cheers.
[/]
- – - – -
Download full paper from:
http://lacal.net/files/NIMAN-KENCH.doc
OPEN SOURCE IN THE PHARMACEUTICAL INDUSTRY
Neil B. Niman, University of New Hampshire
Brian T. Kench, University of Tampa
ABSTRACT
Recent evidence suggests that pharmaceutical companies focus more on managing their intellectual property rights than in developing drugs that cure medical problems. The open source movement offers alternate rules for the process of developing new drugs and managing intellectual property rights. The essence of open source is to radically change the development process before there exists something worthy of being assigned a set of rights. Open source in the pharmaceutical industry also offers the potential to reduce the time it takes to develop breakthroughs, test their viability and safety, and bring them to market.